DeutschNewstral
Article
Bbarrons.com on 2021-07-07 15:41
Emergent BioSolutions Faces Lawsuits Related to Vaccine Troubles3 min read
Related news
- BFDA Approves Narcan for Over-the-Counter Use. Emergent Biosolutions Surges.1 min readbarrons.com
Is The Worst Over For Emergent Biosolutions Stock?Forbes- MCongressional investigation initiated into Emergent BioSolutions’ vaccine contractsmvtelegraph.com
- BEmergent BioSolutions Stock Falls After Vaccine Factory Mix-Upbarrons.com
Emergent BioSolutions expands Baltimore facilitythedailyrecord.com- VHealth Canada on AstraZeneca, Janssen COVID-19 vaccines produced at Emergent BioSolutionsvoiceonline.com
Emergent BioSolutions lands $22 million order to make Zika vaccine candidatebaltimoresun.com
Emergent BioSolutions to expand, add Md. jobsbizjournals.com- Emergent BioSolutions competitor gets $143M federal contract for anthrax vaccine workbizjournals.com
- Emergent BioSolutions to close Baltimore, Rockville plants, lay off 300 workersbaltimoresun.com
- Emergent BioSolutions to spin off biosciences companybizjournals.com
- What’s Happening With Emergent Biosolutions Stock?Forbes
- Emergent BioSolutions gets $19.7 million Ebola contractbizjournals.com
FDA OK's Emergent BioSolutions plant to resume manufacturing J&J's Covid vaccineCNN- Emergent Biosolutions Stock Takes A Hit From Vaccine Mix-Up At Baltimore PlantForbes
Committees’ report on emergent BioSolutions uncovers extensive vaccine manufacturing failures, clear efforts to hide deficienciesafro.com- Emergent BioSolutions manufacturing Ebola treatment in Baltimorebaltimoresun.com
- BMonkeypox Case Reported in U.S. Emergent BioSolutions Makes a Vaccine.1 min readbarrons.com
- BEmergent BioSolutions Stock Plunges After Key Government Contract Terminated1 min readbarrons.com
- Emergent BioSolutions to acquire anthrax treatment, move manufacturing to Baltimorebaltimoresun.com